サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629310

生体吸収性血管足場市場：タイプ別、材料タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Bioresorbable Vascular Scaffold Market, By Type, By Material Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 311 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
生体吸収性血管足場市場：タイプ別、材料タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

生体吸収性血管足場の市場規模は2023年に3億9,850万米ドルとなり、2024年から2032年にかけてCAGR 8.90％で拡大

生体吸収性血管足場市場 - 市場力学

心血管疾患の有病率の増加が先進治療への需要を促進

心血管疾患（CVD）の有病率の増加は、生体吸収性血管足場（BVS）市場の主要促進要因です。CVDの世界の負担が増加するにつれて、冠動脈の健康をサポートするBVSのような高度な治療に対するニーズが高まっています。世界保健機関（WHO）によると、CVDは世界の死因の第1位であり、年間推定死亡者数は1,790万人、世界全体の死亡者数の32％を占めています。米国では、疾病対策予防センター（CDC）の報告によると、20歳以上の成人約1,820万人が冠動脈疾患を患っており、BVSのような革新的なソリューションの必要性が浮き彫りになっています。CVDの罹患率が上昇を続ける中、生体吸収性足場のような効果的で低侵襲な治療に対する需要は拡大し、市場を牽引していくと予想されます。

生体吸収性血管足場市場 - 主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約8.90%のCAGRで毎年成長すると推定されています。

タイプ別セグメントでは、薬剤溶出性生体吸収性血管足場が2023年に最大市場シェアを示すと予測されています。

材料タイプ別では、ポリ乳酸（PLA）が2023年に主要セグメントとなりました。

用途別では、冠動脈疾患治療が2023年の主要セグメントでした。

地域別では、北米が2023年の主要収益源でした。

生体吸収性血管足場市場 - セグメンテーション分析：

世界の生体吸収性血管足場市場は、タイプ、材料タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって、薬剤溶出性生体吸収性血管足場、非薬剤溶出性生体吸収性血管足場に分類されます。薬剤溶出性生体吸収性血管足場セグメントは、生体吸収性血管足場（BVS）市場で最も顕著です。これらの足場は、細胞の増殖を抑制することで再狭窄（動脈の再狭窄）を防ぐ薬剤でコーティングされており、長期的な治療成績を確保する上で非常に効果的です。薬剤溶出機能が加わることで合併症のリスクが大幅に軽減されるため、これらの足場はヘルスケアプロバイダーや患者の間で人気が高まっています。冠動脈疾患の治療では再狭窄を最小限に抑え、臨床結果を改善することがますます重視されるようになり、薬剤溶出性BVSが好まれるようになっています。さらに、これらの足場は生体吸収とドラッグデリバリーの両方の利点を併せ持ち、優れた治療効果をもたらします。このセグメントの成長は、北米や欧州などの地域で進行中の臨床研究やさまざまな薬剤溶出型BVS製品の承認によってさらに支えられています。その結果、薬剤溶出セグメントは市場において優位性を維持すると予想されます。

市場は材料タイプによって、ポリ乳酸（PLA）、ポリL乳酸（PLLA）、マグネシウムベース、その他に分けられます。ポリ乳酸（PLA）セグメントは、生体吸収性血管足場（BVS）市場で最も顕著です。PLAはその生体適合性、生分解性、機械的特性により広く使用されており、血管足場として理想的な材料です。治癒過程で動脈を支えるのに必要な強度と柔軟性を提供すると同時に、徐々に体内に吸収されるため、永久ステントに伴う長期的な合併症を軽減することができます。様々なドラッグデリバリーシステムでの使用など、PLAの医療用途における確立された実績は、BVS市場におけるPLAの大きな存在感につながっています。このセグメントの成長を牽引しているのは、低侵襲ソリューションに対する需要の高まりと、臨床試験におけるPLAベースの足場技術の進歩です。有効性が証明され、有利な特性を持つことから、PLAは市場での優位性を維持すると予想されます。

生体吸収性血管足場市場 - 地理的洞察

北米は生体吸収性血管足場（BVS）市場の主要地域であり、心血管疾患の罹患率の高さと高度なヘルスケアインフラがその要因となっています。米国が最大の市場シェアを占めており、アボットラボラトリーズ、メドトロニック、ボストンサイエンティフィックなど、生体吸収性足場の開発と普及に積極的な主要医療機器企業の存在感が大きいです。この地域は、FDAによる生体吸収性デバイスの承認や強力なヘルスケア償還政策など、良好な規制環境の恩恵を受けています。カナダも革新的な心血管系治療に重点を置くようになり、成長に貢献しています。さらに、米国とカナダでは、広範な調査、臨床試験、ヘルスケアプロバイダーによる新技術の早期導入が、市場拡大をさらに後押ししています。低侵襲手技への需要の高まりと先進ステント技術の採用は、BVS市場における北米の優位性を維持すると予想されます。

生体吸収性血管足場市場 - 競合情勢：

生体吸収性血管足場（BVS）市場の競合情勢は、アボットラボラトリーズ、ボストンサイエンティフィックコーポレーション、メドトロニック、ビオトロニックなどの主要企業が占めています。アボットはAbsorb BVSで知られ、高性能足場と広範な臨床試験に注力しています。ボストンサイエンティフィックは生体吸収性足場技術を進歩させ、臨床転帰の改善を重視しています。メドトロニックはBVSを含む様々な心血管ソリューションで革新を続けており、バイオトロニックは血管インターベンションに特化し、機器の安全性と有効性を高めるための臨床研究に投資しています。これらの企業は、技術革新、臨床エビデンスの拡大、規制当局の承認の確保によって、市場をリードしようと競い合っています。

目次

第1章 生体吸収性血管足場の市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 生体吸収性血管足場の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 生体吸収性血管足場の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 生体吸収性血管足場市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 生体吸収性血管足場の市場情勢

  • 生体吸収性血管足場市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 生体吸収性血管足場市場 - タイプ別

  • 概要
    • セグメントシェア分析 - タイプ別
    • 薬剤溶出型生体吸収性血管足場
    • 非薬剤溶出性生体吸収性血管足場

第8章 生体吸収性血管足場市場 - 材料タイプ別

  • 概要
    • セグメントシェア分析 - 材料タイプ別
    • ポリ乳酸（PLA）
    • ポリ-L-乳酸（PLLA）
    • マグネシウムベース
    • その他

第9章 生体吸収性血管足場市場 - 用途別

  • 概要
    • セグメントシェア分析 - 用途別
    • 冠動脈疾患の治療
    • 末梢動脈疾患の治療
    • その他

第10章 生体吸収性血管足場市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析 - エンドユーザー別
    • 病院
    • 外来手術センター
    • 心臓カテーテル検査室
    • その他

第11章 生体吸収性血管足場市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 生体吸収性血管足場業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik
    • Terumo Corporation
    • Stratmotive Technologies（SMT）
    • Reva Medical
    • Koninklijke Philips
    • MIV Therapeutics
    • Stentys
    • Biocube
    • Bioabsorbable Vascular Scaffold Solutions（BVSS）
    • Vascular Concepts
    • Elixir Medical
    • KalliTech
    • Endologix
    • Camtech

第13章 アナリストの全方位展望

目次
Product Code: ANV4459

REPORT HIGHLIGHT

The Bioresorbable Vascular Scaffold Market size was valued at USD 398.50 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The bioresorbable vascular scaffold market focuses on devices designed to treat coronary artery disease by temporarily supporting blood vessels and gradually dissolving over time. These scaffolds, made from biocompatible materials, provide a solution to traditional stents by eventually being absorbed by the body. The growing prevalence of cardiovascular diseases and the demand for less invasive, more efficient treatments are driving the market. Technological advancements in scaffold materials and minimally invasive procedures further contribute to its growth. Despite this, challenges such as high costs and concerns about long-term clinical outcomes compared to traditional metallic stents are hindering widespread adoption. The North American and European markets are dominant, while Asia Pacific is experiencing rapid growth due to better healthcare access and rising awareness.

Bioresorbable Vascular Scaffold Market- Market Dynamics

The increasing prevalence of cardiovascular diseases drives demand for advanced treatments.

The increasing prevalence of cardiovascular diseases (CVD) is a key driver for the bioresorbable vascular scaffold (BVS) market. As the global burden of CVD rises, there is a greater need for advanced treatments like BVS to support coronary artery health. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, responsible for an estimated 17.9 million deaths annually, which accounts for 32% of all global deaths. In the United States, the Centers for Disease Control and Prevention (CDC) reports that nearly 18.2 million adults aged 20 and older have coronary artery disease, highlighting the need for innovative solutions such as BVS. As the incidence of CVD continues to rise, the demand for effective, minimally invasive treatments like bioresorbable scaffolds is expected to grow, driving the market forward.

Bioresorbable Vascular Scaffold Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Type segmentation, drug-eluting bioresorbable vascular scaffold was predicted to show maximum market share in the year 2023

Based on Material Type segmentation, Polylactic Acid (PLA) was the leading segment in 2023

Based on Application segmentation, Coronary Artery Disease Treatment was the leading segment in 2023

based on region, North America was the leading revenue generator in 2023

Bioresorbable Vascular Scaffold Market- Segmentation Analysis:

The Global Bioresorbable Vascular Scaffold Market is segmented based on Type, Material Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Drug-eluting bioresorbable vascular scaffold, non-drug-eluting bioresorbable vascular scaffold. The drug-eluting bioresorbable vascular scaffold segment is the most prominent in the bioresorbable vascular scaffold (BVS) market. These scaffolds are coated with medications that help prevent restenosis (re-narrowing of the artery) by inhibiting cell growth, making them highly effective in ensuring long-term treatment outcomes. The addition of drug-eluting capabilities significantly reduces the risk of complications, which has made these scaffolds more popular among healthcare providers and patients. As coronary artery disease treatments increasingly focus on minimizing restenosis and improving clinical results, drug-eluting BVSs are gaining preference. Moreover, these scaffolds combine the benefits of both biosorption and drug delivery, providing superior therapeutic efficacy. This segment's growth is further supported by ongoing clinical studies and the successful approval of various drug-eluting BVS products in regions like North America and Europe. Consequently, the drug-eluting segment is expected to remain dominant in the market.

The market is divided into two categories based on Material Type: Polylactic Acid (PLA), Poly-L-lactic Acid (PLLA), Magnesium-Based, and Others. The Polylactic Acid (PLA) segment is the most prominent in the bioresorbable vascular scaffold (BVS) market. PLA is widely used due to its biocompatibility, biodegradability, and mechanical properties that make it an ideal material for vascular scaffolds. It offers the necessary strength and flexibility required to support the artery during the healing process, while also gradually resorbing into the body, reducing long-term complications associated with permanent stents. PLA's established track record in medical applications, including its use in various drug delivery systems, contributes to its significant presence in the BVS market. The segment's growth is driven by the increasing demand for minimally invasive solutions and the advancement of PLA-based scaffold technologies in clinical trials. Given its proven effectiveness and favorable properties, PLA is expected to maintain its dominance in the market.

Bioresorbable Vascular Scaffold Market- Geographical Insights

North America is the leading region in the bioresorbable vascular scaffold (BVS) market, driven by the high incidence of cardiovascular diseases and advanced healthcare infrastructure. The United States holds the largest market share, supported by a strong presence of leading medical device companies such as Abbott Laboratories, Medtronic, and Boston Scientific, which are actively developing and promoting bioresorbable scaffolds. The region benefits from favorable regulatory environments, including the FDA's approval of bioresorbable devices, along with strong healthcare reimbursement policies. Canada also contributes to the growth, with a growing emphasis on innovative cardiovascular treatments. Additionally, extensive research, clinical trials, and early adoption of new technologies by healthcare providers in the U.S. and Canada further fuel market expansion. The increasing demand for minimally invasive procedures and the adoption of advanced stent technologies are expected to maintain North America's dominance in the BVS market.

Bioresorbable Vascular Scaffold Market- Competitive Landscape:

The competitive landscape of the bioresorbable vascular scaffold (BVS) market is dominated by key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic, and Biotronik. Abbott is recognized for its Absorb BVS, focusing on high-performance scaffolds and extensive clinical trials. Boston Scientific is advancing bioresorbable scaffold technology, emphasizing improved clinical outcomes. Medtronic continues to innovate with a range of cardiovascular solutions, including BVS, while Biotronik specializes in vascular interventions and invests in clinical studies to enhance device safety and effectiveness. These companies are competing to lead the market by innovating, expanding clinical evidence, and securing regulatory approvals.

Recent Developments:

In April 2024, the FDA approved Abbott's Esprit BTK, an everolimus-eluting bioresorbable scaffold, for the treatment of patients with below-the-knee (BTK) infra popliteal disease. This approval marks the first-ever device authorized by the FDA specifically for BTK lesions. The decision was based on the positive results from the LIFE-BTK study, which showed reduced risks of amputation, vessel occlusion, revascularization, and restenosis compared to conventional angioplasty.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic
  • Biotronik
  • Terumo Corporation
  • Stratmotive Technologies (SMT)
  • Reva Medical
  • Koninklijke Philips
  • MIV Therapeutics
  • Stentys
  • Biocube
  • Bioabsorbable Vascular Scaffold Solutions (BVSS)
  • Vascular Concepts
  • Elixir Medical
  • KalliTech
  • Endologix
  • Camtech

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug-eluting bioresorbable Vascular Scaffold
  • Non-Drug-Eluting Bioresorbable Vascular Scaffold

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polylactic Acid (PLA)
  • Poly-L-lactic Acid (PLLA)
  • Magnesium-Based
  • Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Coronary Artery Disease Treatment
  • Peripheral Artery Disease Treatment
  • Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioresorbable Vascular Scaffold Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioresorbable Vascular Scaffold Market Snippet by Type
    • 2.1.2. Bioresorbable Vascular Scaffold Market Snippet by Material Type
    • 2.1.3. Bioresorbable Vascular Scaffold Market Snippet by Application
    • 2.1.4. Bioresorbable Vascular Scaffold Market Snippet by End-User
    • 2.1.5. Bioresorbable Vascular Scaffold Market Snippet by Country
    • 2.1.6. Bioresorbable Vascular Scaffold Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioresorbable Vascular Scaffold Key Market Trends

  • 3.1. Bioresorbable Vascular Scaffold Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioresorbable Vascular Scaffold Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioresorbable Vascular Scaffold Market Opportunities
  • 3.4. Bioresorbable Vascular Scaffold Market Future Trends

4. Bioresorbable Vascular Scaffold Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioresorbable Vascular Scaffold Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioresorbable Vascular Scaffold Market Landscape

  • 6.1. Bioresorbable Vascular Scaffold Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioresorbable Vascular Scaffold Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Drug-eluting bioresorbable Vascular Scaffold
    • 7.1.3. Non-Drug-Eluting Bioresorbable Vascular Scaffold

8. Bioresorbable Vascular Scaffold Market - By Material Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Material Type, 2023 & 2032 (%)
    • 8.1.2. Polylactic Acid (PLA)
    • 8.1.3. Poly-L-lactic Acid (PLLA)
    • 8.1.4. Magnesium-Based
    • 8.1.5. Others

9. Bioresorbable Vascular Scaffold Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Coronary Artery Disease Treatment
    • 9.1.3. Peripheral Artery Disease Treatment
    • 9.1.4. Others

10. Bioresorbable Vascular Scaffold Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Cardiac Catheterization Laboratories
    • 10.1.5. Others

11. Bioresorbable Vascular Scaffold Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Bioresorbable Vascular Scaffold Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Bioresorbable Vascular Scaffold Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Bioresorbable Vascular Scaffold Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Bioresorbable Vascular Scaffold Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Bioresorbable Vascular Scaffold Key Manufacturers in the Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Bioresorbable Vascular Scaffold Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Boston Scientific Corporation
    • 12.2.3. Medtronic
    • 12.2.4. Biotronik
    • 12.2.5. Terumo Corporation
    • 12.2.6. Stratmotive Technologies (SMT)
    • 12.2.7. Reva Medical
    • 12.2.8. Koninklijke Philips
    • 12.2.9. MIV Therapeutics
    • 12.2.10. Stentys
    • 12.2.11. Biocube
    • 12.2.12. Bioabsorbable Vascular Scaffold Solutions (BVSS)
    • 12.2.13. Vascular Concepts
    • 12.2.14. Elixir Medical
    • 12.2.15. KalliTech
    • 12.2.16. Endologix
    • 12.2.17. Camtech

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us